Patricia Eckert's most recent trade in Enzo Biochem, Inc. was a trade of 100,000 Stock Option (to acquire shares of Common Stock) done . Disclosure was reported to the exchange on Aug. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enzo Biochem, Inc. | Patricia Eckert | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Aug 2025 | 100,000 | 0 | - | - | Stock Option (to acquire shares of Common Stock) | |
| Enzo Biochem, Inc. | Patricia Eckert | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Aug 2025 | 75,000 | 0 | - | - | Stock Option (to acquire shares of Common Stock) | |
| Enzo Biochem, Inc. | Patricia Eckert | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Aug 2025 | 50,000 | 0 | - | - | Stock Option (to acquire shares of Common Stock) | |
| Enzo Biochem, Inc. | Patricia Eckert | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Aug 2025 | 28,328 | 0 (0%) | 0% | - | Common Stock | |
| Enzo Biochem, Inc. | Patricia Eckert | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Aug 2025 | 25,000 | 0 | - | - | Stock Option (to acquire shares of Common Stock) | |
| Enzo Biochem, Inc. | Patricia Eckert | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Aug 2025 | 25,000 | 0 | - | - | Stock Option (to acquire shares of Common Stock) | |
| Enzo Biochem, Inc. | Patricia Eckert | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 100,000 | 100,000 | - | - | Stock Option (to acquire shares of Common Stock) | |
| Enzo Biochem, Inc. | Patricia Eckert | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 75,000 | 75,000 | - | - | Stock Option (to acquire shares of Common Stock) | |
| Enzo Biochem, Inc. | Patricia Eckert | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 25,000 | 25,000 | - | - | Stock Option (to acquire Common Stock) |